SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-001035
Filing Date
2021-01-21
Accepted
2021-01-21 17:29:50
Documents
16
Period of Report
2021-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20210121_8k.htm   iXBRL 8-K 36499
2 EXHIBIT 1.1 ex_221691.htm EX-1.1 286728
3 EXHIBIT 5.1 ex_221690.htm EX-5.1 10380
8 cooleylogo01.jpg GRAPHIC 14596
  Complete submission text file 0001437749-21-001035.txt   553906

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210119.xsd EX-101.SCH 3701
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210119_def.xml EX-101.DEF 11587
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210119_lab.xml EX-101.LAB 15467
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210119_pre.xml EX-101.PRE 11741
9 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210121_8k_htm.xml XML 2565
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 21543039
SIC: 2834 Pharmaceutical Preparations